These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 6138990

  • 1. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H, Nowak R, Donner A, Kunkel M, Gärtner L, Scholtz HJ.
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [Abstract] [Full Text] [Related]

  • 2. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G, Bitzer M, Bross KJ, Brugger W, Boldt C, Hirsch FW, Weitzmann U, Löhr GW.
    Dtsch Med Wochenschr; 1984 Nov 30; 109(48):1837-43. PubMed ID: 6094138
    [Abstract] [Full Text] [Related]

  • 3. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH, Pearson GR, Armstrong M, Bengali Z, Berenberg J, Easton J, Goepfert H, Henle G, Henle W, Heffner D, Huang A, Hyams VJ, Lanier A, Neel HB, Pilch B, Pointek N, Taylor W, Terebelo H, Weiland L.
    Cancer Detect Prev; 1981 Nov 30; 4(1-4):307-12. PubMed ID: 6299561
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of IgG and IgA type antibodies to capsid and early antigens of the Epstein-Barr virus in the diagnosis of nasopharyngeal carcinoma].
    Mendoza J, Rojas A, de la Rosa M, Amador JM, Expósito J, Esquivias J.
    Med Clin (Barc); 1991 Nov 09; 97(16):609-11. PubMed ID: 1662737
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Nov 09; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 6. Malaria antibody levels in patients with nasopharyngeal carcinoma.
    Yadav M, Prasad U.
    Southeast Asian J Trop Med Public Health; 1984 Jun 09; 15(2):234-7. PubMed ID: 6095462
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
    Kaschka WP, Hilgers R, Skvaril F.
    Clin Exp Immunol; 1982 Jul 09; 49(1):149-56. PubMed ID: 6290114
    [Abstract] [Full Text] [Related]

  • 10. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, Frikha M, Jlidi R, Middeldorp JM.
    J Med Virol; 2005 Apr 09; 75(4):593-602. PubMed ID: 15714486
    [Abstract] [Full Text] [Related]

  • 11. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
    Tiwawech D, Srivatanakul P, Karaluk A, Ishida T.
    Asian Pac J Cancer Prev; 2003 Apr 09; 4(2):113-8. PubMed ID: 12875623
    [Abstract] [Full Text] [Related]

  • 12. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, Hassar M, Khyatti M.
    J Clin Virol; 2008 Feb 09; 41(2):96-103. PubMed ID: 18024156
    [Abstract] [Full Text] [Related]

  • 13. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma.
    Ammatuna P, de Thè G, Speciale R, Sammartano F, Arista S, Zerillo G.
    Microbiologica; 1988 Apr 09; 11(2):89-94. PubMed ID: 2841559
    [Abstract] [Full Text] [Related]

  • 14. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
    Faggioni A, Corradini C, Venanzoni M, Cardi G, Bevere F, Barile G, Zompetta C, Frati L.
    J Exp Pathol; 1987 Apr 09; 3(4):471-7. PubMed ID: 2842480
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. EBV-specific humoral antibodies in nasopharyngeal carcinoma patients in Cuba.
    Ruiz R, Gurtsevich V, Le Riverend E.
    Neoplasma; 1979 Apr 09; 26(2):125-31. PubMed ID: 224330
    [Abstract] [Full Text] [Related]

  • 19. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP.
    Oral Oncol; 2008 Aug 09; 44(8):784-92. PubMed ID: 18206420
    [Abstract] [Full Text] [Related]

  • 20. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM.
    J Clin Microbiol; 2006 Apr 09; 44(4):1459-67. PubMed ID: 16597877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.